Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
CSRMF's Cash to Debt is ranked higher than
90% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. CSRMF: No Debt )
CSRMF' s 10-Year Cash to Debt Range
Min: 0.05   Max: No Debt
Current: No Debt

Equity to Asset 0.73
CSRMF's Equity to Asset is ranked higher than
81% of the 298 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. CSRMF: 0.73 )
CSRMF' s 10-Year Equity to Asset Range
Min: 0.43   Max: 0.73
Current: 0.73

0.43
0.73
Interest Coverage 8.08
CSRMF's Interest Coverage is ranked higher than
57% of the 204 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.30 vs. CSRMF: 8.08 )
CSRMF' s 10-Year Interest Coverage Range
Min: 2.41   Max: 50.87
Current: 8.08

2.41
50.87
F-Score: 5
Z-Score: 6.22
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 16.36
CSRMF's Operating margin (%) is ranked higher than
86% of the 301 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.30 vs. CSRMF: 16.36 )
CSRMF' s 10-Year Operating margin (%) Range
Min: 1.28   Max: 22.55
Current: 16.36

1.28
22.55
Net-margin (%) 24.07
CSRMF's Net-margin (%) is ranked higher than
95% of the 301 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.08 vs. CSRMF: 24.07 )
CSRMF' s 10-Year Net-margin (%) Range
Min: -22.63   Max: 24.07
Current: 24.07

-22.63
24.07
ROE (%) 23.51
CSRMF's ROE (%) is ranked higher than
94% of the 297 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. CSRMF: 23.51 )
CSRMF' s 10-Year ROE (%) Range
Min: -31.1   Max: 51.49
Current: 23.51

-31.1
51.49
ROA (%) 17.12
CSRMF's ROA (%) is ranked higher than
96% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.54 vs. CSRMF: 17.12 )
CSRMF' s 10-Year ROA (%) Range
Min: -20.96   Max: 24.18
Current: 17.12

-20.96
24.18
ROC (Joel Greenblatt) (%) 31.77
CSRMF's ROC (Joel Greenblatt) (%) is ranked higher than
84% of the 303 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.55 vs. CSRMF: 31.77 )
CSRMF' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 1.59   Max: 43.83
Current: 31.77

1.59
43.83
Revenue Growth (%) -6.90
CSRMF's Revenue Growth (%) is ranked higher than
58% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. CSRMF: -6.90 )
CSRMF' s 10-Year Revenue Growth (%) Range
Min: -7.9   Max: 16.5
Current: -6.9

-7.9
16.5
EBITDA Growth (%) 6.10
CSRMF's EBITDA Growth (%) is ranked higher than
72% of the 237 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.40 vs. CSRMF: 6.10 )
CSRMF' s 10-Year EBITDA Growth (%) Range
Min: -17.9   Max: 23.5
Current: 6.1

-17.9
23.5
EPS Growth (%) 12.10
CSRMF's EPS Growth (%) is ranked higher than
79% of the 240 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.80 vs. CSRMF: 12.10 )
CSRMF' s 10-Year EPS Growth (%) Range
Min: -39.7   Max: 57.3
Current: 12.1

-39.7
57.3
» CSRMF's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with CSRMF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 11.10
CSRMF's P/E(ttm) is ranked higher than
96% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 34.30 vs. CSRMF: 11.10 )
CSRMF' s 10-Year P/E(ttm) Range
Min: 9.08   Max: 74.88
Current: 11.1

9.08
74.88
P/B 2.57
CSRMF's P/B is ranked higher than
77% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.20 vs. CSRMF: 2.57 )
CSRMF' s 10-Year P/B Range
Min: 1.27   Max: 3.47
Current: 2.57

1.27
3.47
P/S 2.66
CSRMF's P/S is ranked higher than
74% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. CSRMF: 2.66 )
CSRMF' s 10-Year P/S Range
Min: 0.75   Max: 3.11
Current: 2.66

0.75
3.11
PFCF 30.43
CSRMF's PFCF is ranked higher than
83% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 68.44 vs. CSRMF: 30.43 )
CSRMF' s 10-Year PFCF Range
Min: 8.43   Max: 79.43
Current: 30.43

8.43
79.43
EV-to-EBIT 13.65
CSRMF's EV-to-EBIT is ranked higher than
90% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.61 vs. CSRMF: 13.65 )
CSRMF' s 10-Year EV-to-EBIT Range
Min: 8.9   Max: 38
Current: 13.65

8.9
38
PEG 4.00
CSRMF's PEG is ranked higher than
84% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CSRMF: 4.00 )
CSRMF' s 10-Year PEG Range
Min: 0.65   Max: 110.47
Current: 4

0.65
110.47
Shiller P/E 23.38
CSRMF's Shiller P/E is ranked higher than
92% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CSRMF: 23.38 )
CSRMF' s 10-Year Shiller P/E Range
Min: 13.8   Max: 79.56
Current: 23.38

13.8
79.56

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.80
CSRMF's Dividend Yield is ranked higher than
76% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.36 vs. CSRMF: 1.80 )
CSRMF' s 10-Year Dividend Yield Range
Min: 1.79   Max: 5.74
Current: 1.8

1.79
5.74
Dividend Payout 0.26
CSRMF's Dividend Payout is ranked higher than
88% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CSRMF: 0.26 )
CSRMF' s 10-Year Dividend Payout Range
Min: 0.16   Max: 2.25
Current: 0.26

0.16
2.25
Yield on cost (5-Year) 1.80
CSRMF's Yield on cost (5-Year) is ranked higher than
70% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.41 vs. CSRMF: 1.80 )
CSRMF' s 10-Year Yield on cost (5-Year) Range
Min: 1.79   Max: 5.74
Current: 1.8

1.79
5.74
Share Buyback Rate -0.10
CSRMF's Share Buyback Rate is ranked higher than
84% of the 237 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.20 vs. CSRMF: -0.10 )
CSRMF' s 10-Year Share Buyback Rate Range
Min: -0.1   Max: -2.2
Current: -0.1

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 65.21
CSRMF's Price/Net Current Asset Value is ranked higher than
82% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CSRMF: 65.21 )
CSRMF' s 10-Year Price/Net Current Asset Value Range
Min: 57.14   Max: 57.14
Current: 65.21

Price/Tangible Book 3.25
CSRMF's Price/Tangible Book is ranked higher than
82% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.81 vs. CSRMF: 3.25 )
CSRMF' s 10-Year Price/Tangible Book Range
Min: 1.25   Max: 24.78
Current: 3.25

1.25
24.78
Price/DCF (Projected) 1.79
CSRMF's Price/DCF (Projected) is ranked higher than
83% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.15 vs. CSRMF: 1.79 )
CSRMF' s 10-Year Price/DCF (Projected) Range
Min: 0.68   Max: 5.31
Current: 1.79

0.68
5.31
Price/Median PS Value 1.77
CSRMF's Price/Median PS Value is ranked higher than
61% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.16 vs. CSRMF: 1.77 )
CSRMF' s 10-Year Price/Median PS Value Range
Min: 0.57   Max: 1.85
Current: 1.77

0.57
1.85
Price/Peter Lynch Fair Value 3.98
CSRMF's Price/Peter Lynch Fair Value is ranked higher than
87% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CSRMF: 3.98 )
CSRMF' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.97   Max: 3.49
Current: 3.98

0.97
3.49
Price/Graham Number 1.86
CSRMF's Price/Graham Number is ranked higher than
88% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.82 vs. CSRMF: 1.86 )
CSRMF' s 10-Year Price/Graham Number Range
Min: 1.02   Max: 4.4
Current: 1.86

1.02
4.4
Earnings Yield (Greenblatt) 7.30
CSRMF's Earnings Yield (Greenblatt) is ranked higher than
84% of the 261 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. CSRMF: 7.30 )
CSRMF' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.6   Max: 11.3
Current: 7.3

2.6
11.3
Forward Rate of Return (Yacktman) 8.04
CSRMF's Forward Rate of Return (Yacktman) is ranked higher than
78% of the 260 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.99 vs. CSRMF: 8.04 )
CSRMF' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -12   Max: 20.9
Current: 8.04

-12
20.9

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare: » details
Traded in other countries:CSRT.UK
Consort Medical PLC & its subsidiaries, are engaged in the design, development and manufacture of specialty medical drug delivery devices and services to the pharmaceutical industry through its Bespak division and disposable airway management products for critical care settings in hospitals and pre-hospital settings through its King Systems division. Its products include metered dose inhalers, dry powder devices, actuators, compliance aids, disposable autoinjectors, needle-free reusable jet injectors, disposable facemasks, breathing circuits, laryngeal tubes and video laryngoscopes. It operates through two divisions: Bespak and King Systems. Bespak is the drug delivery device division, engaged in the supply of valves and other devices for respiratory applications and autoinjectors to global pharmaceutical companies. King Systems is a supplier of life-saving patient care solutions to the US anaesthesia market including breathing circuits, face masks and other disposable airway management and airway visualisation products. Its operations are based in the UK, Europe and the USA.
» More Articles for OTCPK:CSRMF

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
No related articles found.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK